- Global Pharma News & Resources

Digital Genome Market was valued at US$ 7,594.8 million in 2020 and is projected to reach US$ 17.3 Billion by 2028, growing at a CAGR of 10.9% from 2021 to 2028

The digital genome consists of a complete digital collection of DNA material that occurs within an organism or a cell. It's a simpler method to collect genetic data concerning hereditary disorders and is used extensively by geneticists for a closer look at potential genetic illnesses. It was first intended to be a tool of diagnosis but has evolved into a powerful research tool.

The growing popularity of the human genome projects is a prime factor fueling the market growth of the digital genome.  According to Forbes, by 2025, it’s projected that 100 million genomes will be sequenced. Increasing funding for genomics is another major factor in augmenting the market growth.

Ask for PDF Brochure:

Growing development in the field of biotechnology due to rising healthcare needs and increasing investment by the government is again driving the market growth. Additionally, the growing demand for personalized medicines coupled with the penetration of new players and start-ups across developing economies is also projected to foster market growth. Furthermore, the increasing prevalence of the chronic disease is further projected to propel the market growth of the digital genome.

North America is expected to gain significant growth over the forecast period and this is attributed to the increasing research and development in biotechnology in the region. Moreover, the continuous launch of innovative products in the field of the digital genome is again expected to fuel the regional market growth. For instance, in October 2019, Inscripta, Inc., announced the launch of the Onyx™ Digital Genome Engineering platform. It is a fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform — which includes software, consumables, instrument, and assays — enables researchers to engineer microbial libraries containing the full breadth and scope of possible edit types, in their own labs.

Key Developments:

In August 2020, Ancestry has launched an AncestryHealth powered by Next Generation Sequencing,” the tool can screen for genes associated with breast cancer, heart disease, colon cancer, and blood disorders.

in October 2019, MGI has launched its new one-stop sequencing solution, including the portable "express" sequencing system DNBSEQ E series, the modular "digital biolab" DNBelab D series for use with the sequencing system, and a new single "cell" DNBelab C series, a handheld single-cell laboratory that can fit into a pocket.

In February 2020, Twist Bioscience launches twist targeted methylation sequencing solution to study methylation pattern changes in a wide range of research fields including cancer, epigenetics, and non-invasive prenatal testing

Request Here Sample Report:

Top Key Players:

Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC,, Inc., Deep Genomics, Deep Genomics, Deep Genomics, Desktop Genetics Ltd., and LLC.

Digital Genome Market Segmentation

By Product Type:

  • Sequencer & Analyzers
  • Reagents & Kits
  • Sequencing & Analysis Software

By Application:

  • Clinical
  • Reproductive Health
  • Oncology
  • Others
  • Forensics
  • Drug Discovery and Development
  • Other Applications

By End User:

  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Others

Tailored Information as per niche requirement:
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy This Complete A Business Report:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note – In order to provide more accurate Market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Digital Genome Market was valued at US$ 7,594.8 million in 2020 and is projected to reach US$ 17.3 Billion by 2028, growing at a CAGR of 10.9% from 2021 to 2028

Editor Details

Related Links

Last Updated: 27-Jul-2021